UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

High-throughput mutational analysis of urothelial bladder carcinoma

European journal of cancer (1990), 2017-02, Vol.72, p.S192-S192

2017

Link zum Volltext

Verfügbarkeit prüfen

The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer

Oncogene, 2010-09, Vol.29 (39), p.5370-5380

2010

Link zum Volltext

Verfügbarkeit prüfen

RASSF2 associates with and stabilizes the proapoptotic kinase MST2

Oncogene, 2009-08, Vol.28 (33), p.2988-2998

2009

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers

British journal of cancer, 2004-12, Vol.91 (12), p.2071-2078

2004

Link zum Volltext

Verfügbarkeit prüfen

Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability

Journal of clinical pathology, 2008-04, Vol.61 (4), p.524-529

2008

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic regulation of the ras effector tumour suppressor RASSF2 in breast and lung cancer

Oncogene, 2008-03, Vol.27 (12), p.1805-1811

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of the E1A-regulated transcription factor p120(E4F) as an interacting partner of the RASSF1A candidate tumor suppressor gene

Cancer research (Chicago, Ill.), 2004, Vol.64 (1), p.102-107

2004

Link zum Volltext

Verfügbarkeit prüfen

Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma

European journal of cancer (1990), 2002-08, Vol.38 (12), p.1585-1592

2002

Link zum Volltext

Verfügbarkeit prüfen

SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma

British journal of cancer, 2004-01, Vol.90 (2), p.515-521

2004

Link zum Volltext

Verfügbarkeit prüfen

Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma

American journal of human genetics, 2001-07, Vol.69 (1), p.49-54

2001

Link zum Volltext

Verfügbarkeit prüfen

2180A - High-throughput mutational analysis of urothelial bladder carcinoma

European journal of cancer (1990), 2017-02, Vol.72, p.S192-S192

2017

Link zum Volltext

Verfügbarkeit prüfen

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

Oncogene, 2001-03, Vol.20 (12), p.1509-1518

2001

Link zum Volltext

Verfügbarkeit prüfen

The RASSF1A Tumor Suppressor Activates Bax via MOAP-1

The Journal of biological chemistry, 2006-02, Vol.281 (8), p.4557-4563

2006

Link zum Volltext

Verfügbarkeit prüfen

Frequent epigenetic inactivation of the SLIT2 gene in gliomas

Oncogene, 2003-07, Vol.22 (29), p.4611-4616

2003

Link zum Volltext

Verfügbarkeit prüfen

A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (12), p.4244-4250

2004

Link zum Volltext

Verfügbarkeit prüfen

SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells

Cancer research (Chicago, Ill.), 2003-03, Vol.63 (5), p.1054-1058

2003

Link zum Volltext

Verfügbarkeit prüfen

SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers

Cancer research (Chicago, Ill.), 2002-10, Vol.62 (20), p.5874-5880

2002

Link zum Volltext

Verfügbarkeit prüfen

SLC22A1 And ATM Genes Polymorphisms Are Associated With The Risk Of Type 2 Diabetes Mellitus In Western Saudi Arabia: A Case-Control Study

Application of clinical genetics, 2019-01, Vol.12, p.213-219

2019

Link zum Volltext

Verfügbarkeit prüfen

RASSF1A Methylation is Predictive of Poor Prognosis in Female Breast Cancer in a Background of Overall Low Methylation Frequency

Anticancer research, 2011-09, Vol.31 (9), p.2975-2981

2011

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the RASSF1A tumor suppressor gene in controlling cell migration

Cancer research (Chicago, Ill.), 2005-09, Vol.65 (17), p.7653-7659

2005

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers

Oncogene, 2003-03, Vol.22 (10), p.1580-1588

2003

Link zum Volltext

Verfügbarkeit prüfen

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

Oncogene, 2001-11, Vol.20 (51), p.7573-7577

2001

Link zum Volltext

Verfügbarkeit prüfen

Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers

Oncogene, 2002-05, Vol.21 (19), p.3020-3028

2002

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer

Oncogene, 2008, Vol.27 (12), p.1805-1811

2008

Link zum Volltext

Verfügbarkeit prüfen

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours

BREAST CANCER RESEARCH, 2008, Vol.10 (S2), p.P9-P9, Article P9

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-throughput mutational analysis of urothelial bladder carcinoma

The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer

RASSF2 associates with and stabilizes the proapoptotic kinase MST2

Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers

Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability

Epigenetic regulation of the ras effector tumour suppressor RASSF2 in breast and lung cancer

Identification of the E1A-regulated transcription factor p120(E4F) as an interacting partner of the RASSF1A candidate tumor suppressor gene

Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma

SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma

Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma

2180A - High-throughput mutational analysis of urothelial bladder carcinoma

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

The RASSF1A Tumor Suppressor Activates Bax via MOAP-1

Frequent epigenetic inactivation of the SLIT2 gene in gliomas

A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability

SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells

SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers

SLC22A1 And ATM Genes Polymorphisms Are Associated With The Risk Of Type 2 Diabetes Mellitus In Western Saudi Arabia: A Case-Control Study

RASSF1A Methylation is Predictive of Poor Prognosis in Female Breast Cancer in a Background of Overall Low Methylation Frequency

Involvement of the RASSF1A tumor suppressor gene in controlling cell migration

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours

Suchergebnisse filtern